E. Leutenegger

982 total citations
35 papers, 745 citations indexed

About

E. Leutenegger is a scholar working on Surgery, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, E. Leutenegger has authored 35 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Pharmacology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in E. Leutenegger's work include Diabetes Management and Research (4 papers), Pharmacology and Obesity Treatment (3 papers) and Blood Pressure and Hypertension Studies (3 papers). E. Leutenegger is often cited by papers focused on Diabetes Management and Research (4 papers), Pharmacology and Obesity Treatment (3 papers) and Blood Pressure and Hypertension Studies (3 papers). E. Leutenegger collaborates with scholars based in France, Denmark and Canada. E. Leutenegger's co-authors include Corinne Hanotin, Florence Thomas, P Vague, Olivier Ziegler, M Apfelbaum, Pierre Drouin, Alison Layton, A.Y. Finlay, Harald Gollnick and Montserrat Pérez and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

E. Leutenegger

30 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Leutenegger France 11 377 191 176 143 72 35 745
C. Jurado Spain 13 114 0.3× 147 0.8× 36 0.2× 16 0.1× 138 1.9× 31 943
F. Centini Italy 14 127 0.3× 110 0.6× 43 0.2× 11 0.1× 52 0.7× 22 661
Małgorzata Wamil United Kingdom 11 61 0.2× 280 1.5× 141 0.8× 10 0.1× 118 1.6× 26 982
Kung‐Chang Hwang Taiwan 11 142 0.4× 48 0.3× 86 0.5× 39 0.3× 11 0.2× 22 589
Diane Smith United States 11 386 1.0× 240 1.3× 258 1.5× 4 0.0× 90 1.3× 23 763
Fengyang Huang Mexico 16 43 0.1× 144 0.8× 236 1.3× 14 0.1× 15 0.2× 70 846
Fataneh Hashem-Dabaghian Iran 15 99 0.3× 225 1.2× 64 0.4× 24 0.2× 7 0.1× 86 889
Fiona J. Couper United States 19 187 0.5× 45 0.2× 202 1.1× 11 0.1× 193 2.7× 24 918
L. Van Gaal Belgium 14 178 0.5× 489 2.6× 347 2.0× 4 0.0× 25 0.3× 34 1.3k
K. Schroecksnadel Austria 13 54 0.1× 23 0.1× 159 0.9× 19 0.1× 16 0.2× 17 704

Countries citing papers authored by E. Leutenegger

Since Specialization
Citations

This map shows the geographic impact of E. Leutenegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Leutenegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Leutenegger more than expected).

Fields of papers citing papers by E. Leutenegger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Leutenegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Leutenegger. The network helps show where E. Leutenegger may publish in the future.

Co-authorship network of co-authors of E. Leutenegger

This figure shows the co-authorship network connecting the top 25 collaborators of E. Leutenegger. A scholar is included among the top collaborators of E. Leutenegger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Leutenegger. E. Leutenegger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Devillier, Philippe, et al.. (2018). Observance du traitement de fond dans l’asthme persistant de l’adulte en pratique courante. Revue des Maladies Respiratoires. 35(3). 269–278. 2 indexed citations
3.
Flipo, René‐Marc, et al.. (2016). OP0141 Which Strategies in Rheumatoid Arthritis Patient with Inadequate Response To Methotrexate Monotherapy: The Stratege Study. Annals of the Rheumatic Diseases. 75. 109–109. 1 indexed citations
4.
Laurent, B., Éric Vicaut, Alain Leplège, K. Bloch, & E. Leutenegger. (2014). Prevalence and impact on quality of life of post-herpetic neuralgia in French medical centers specialized in chronic pain management: The ZOCAD study. Médecine et Maladies Infectieuses. 44(11-12). 515–524. 10 indexed citations
5.
6.
7.
Dréno, Brigitte, Diane Thiboutot, Harald Gollnick, et al.. (2010). Large‐scale worldwide observational study of adherence with acne therapy. International Journal of Dermatology. 49(4). 448–456. 137 indexed citations
8.
9.
Comet, Denis, et al.. (2009). Études observationnelles en pharmaco-épidémiologie : retour d'expériences et propositions pour une approche pragmatique de la conception, de la conduite et de l'analyse des études. 23(1). 20–28. 1 indexed citations
10.
Ducher, Michel, Laurent Juillard, E. Leutenegger, & Jean Pierre Fauvel. (2008). Major Cardiovascular Risk Factors Are Not Taken Into Account by Physicians When Targeting Blood Pressure Values for Uncontrolled Hypertensive Patients. American Journal of Hypertension. 21(11). 1264–1268. 1 indexed citations
11.
Ducher, Michel, E. Leutenegger, & Jean‐Pierre Fauvel. (2007). Critères subjectifs guidant les médecins pour définir un objectif tensionnel chez l'hypertendu non contrôlé. La Presse Médicale. 36(2). 192–196.
12.
Leutenegger, E., et al.. (2005). La cinquantaine et la ménopause. Plaintes exprimées et non exprimées par les patientes. Perception par les médecins et impact sur la prise en charge. Gynécologie Obstétrique & Fertilité. 33(3). 119–125. 3 indexed citations
13.
Komajda, Michel, et al.. (2001). Ambulatory Heart Failure Management in Private Practice in France. European Journal of Heart Failure. 3(4). 503–507. 22 indexed citations
14.
Apfelbaum, M, P Vague, Olivier Ziegler, et al.. (1999). Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. The American Journal of Medicine. 106(2). 179–184. 263 indexed citations
15.
Hanotin, Corinne, Florence Thomas, Stephen P. Jones, E. Leutenegger, & Pierre Drouin. (1998). A Comparison of Sibutramine and Dexfenfluramine in the Treatment of Obesity. Obesity Research. 6(4). 285–291. 32 indexed citations
16.
Hanotin, Corinne, et al.. (1997). Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study. International Journal of Obesity. 22(1). 32–38. 78 indexed citations
17.
Ratanasavanh, Damrong, et al.. (1996). Metabolism and toxicity of coumarin on cultured human, rat, mouse and rabbit hepatocytes. Fundamental and Clinical Pharmacology. 10(6). 504–510. 31 indexed citations
18.
Singlas, E, et al.. (1995). Pharmacokinetic comparison of oral and local action transcutaneous flurbiprofen in healthy volunteers. Journal of Clinical Pharmacy and Therapeutics. 20(2). 101–107. 31 indexed citations
19.
Coste, Joël, Corinne Hanotin, & E. Leutenegger. (1995). [Prescription of non-steroidal anti-inflammatory agents and risk of iatrogenic adverse effects: a survey of 1072 French general practitioners].. PubMed. 50(3). 265–70. 8 indexed citations
20.
Sechter, D., et al.. (1994). [Action and tolerance of dothiepin hydrochloride (Prothiaden) in depressive states during the evolution of psychotic disorders].. PubMed. 20(4). 445–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Jurado Breakdown of academic impact, for papers by F. Centini Breakdown of academic impact, for papers by Małgorzata Wamil Breakdown of academic impact, for papers by Kung‐Chang Hwang Breakdown of academic impact, for papers by Diane Smith Breakdown of academic impact, for papers by Fengyang Huang Breakdown of academic impact, for papers by Fataneh Hashem-Dabaghian Breakdown of academic impact, for papers by Fiona J. Couper Breakdown of academic impact, for papers by L. Van Gaal Breakdown of academic impact, for papers by K. Schroecksnadel
Rankless by CCL
2026